Mammals harbour a complex gut microbiome, comprising bacteria that confer immunological, metabolic and neurological benefits 1 . Despite advances in sequence-based microbial profiling and myriad studies defining microbiome composition during health and disease, little is known about the molecular processes used by symbiotic bacteria to stably colonize the gastrointestinal tract. We sought to define how mammals assemble and maintain the Bacteroides, one of the most numerically prominent genera of the human microbiome. Here we find that, whereas the gut normally contains hundreds of bacterial species 2,3 , germ-free mice mono-associated with a single Bacteroides species are resistant to colonization by the same, but not different, species. To identify bacterial mechanisms for species-specific saturable colonization, we devised an in vivo genetic screen and discovered a unique class of polysaccharide utilization loci that is conserved among intestinal Bacteroides. We named this genetic locus the commensal colonization factors (ccf). Deletion of the ccf genes in the model symbiont, Bacteroides fragilis, results in colonization defects in mice and reduced horizontal transmission. The ccf genes of B. fragilis are upregulated during gut colonization, preferentially at the colonic surface. When we visualize microbial biogeography within the colon, B. fragilis penetrates the colonic mucus and resides deep within crypt channels, whereas ccf mutants are defective in crypt association. Notably, the CCF system is required for B. fragilis colonization following microbiome disruption with Citrobacter rodentium infection or antibiotic treatment, suggesting that the niche within colonic crypts represents a reservoir for bacteria to maintain long-term colonization. These findings reveal that intestinal Bacteroides have evolved species-specific physical interactions with the host that mediate stable and resilient gut colonization, and the CCF system represents a novel molecular mechanism for symbiosis.
International microbiome sequencing initiatives are revealing detailed inventories of diverse bacterial communities across various body sites, diets and human populations [2] [3] [4] . Complex ecosystems have been forged by co-adaptation over millennia between animals and microbes to create stable and specific microbiomes 5, 6 , suggesting the evolution of molecular mechanisms that establish and maintain symbiotic microbial colonization. Bacteroidetes is one of the most numerically abundant Gram-negative phyla in the mammalian gastrointestinal tract 7 . Studies in the genus Bacteroides have revealed species that induce glycosylation of the intestinal epithelium 8 , produce glycoside hydrolases that digest carbohydrates for host nutrient use 9 , direct host immune maturation 10 and protect animals from inflammation in experimental models of inflammatory bowl disease and multiple sclerosis [11] [12] [13] . To explore the dynamics of microbiome assembly, we sequentially introduced Bacteroides species to germ-free mice and monitored colonization via colony-forming units (c.f.u.) in faeces. Animals were readily colonized with B. fragilis followed by Bacteroides thetaiotaomicron (Fig. 1a ) or Bacteroides vulgatus (Fig. 1b) , and altering the sequence of microbial exposure does not affect results ( Supplementary Fig. 1a ). Notably, however, animals colonized with B. fragilis and then exposed to the same species (marked by an antibiotic resistance gene) are resistant to super-colonization and clear the challenging strain ( Fig. 1c ). This novel observation of 'colonization resistance' by the same species is conserved in three other Bacteroides ( Supplementary Fig. 1b-d) , regardless of the antibiotic resistance markers used ( Supplementary  Fig. 1e ), but not in Escherichia coli ( Supplementary Fig. 1f ). As conventional mice typically harbour 10 11 -10 12 c.f.u. per gram of caecal content 14 (100-fold greater than Bacteroides in mono-association), there does not seem to be a shortage of space or nutrients under these conditions, using a nutrient-rich standard diet. We thus proposed that individual Bacteroides species colonize the gut by saturating a limited and unique niche. Indeed, treatment of B. fragilis mono-associated mice with erythromycin to displace the existing strain permits colonization by an erythromycin-resistant challenge strain (Fig. 1d ). These data suggest that Bacteroides colonize the gut in a species-specific and saturable manner.
We developed a functional in vivo screen to identify genetic factor(s) from B. fragilis that are sufficient to mediate species-specific colonization. Mice were mono-associated with B. vulgatus, then challenged with a library of B. vulgatus clones that each contained a fragment of B. fragilis genomic DNA (schematic in Supplementary Fig. 2a ). We reasoned that only those clones containing genes that conferred stable gut colonization by B. fragilis would persist, with the remainder being cleared. We screened 2,100 clones each containing 9-10 kilobases of DNA, providing a 3.8-fold coverage of the B. fragilis genome and 98% probability that a given DNA sequence is present in the library (Supplementary Equation (1)). Notably, 30 days after orally gavaging the library into animals, only two clones sustained colonization. The inserts from both clones mapped to the same locus on the B. fragilis genome, BF3579-BF3583 ( Supplementary Fig. 2b ).
On the basis of predicted protein sequences, BF3583 and BF3582 constitute a sigma (s) factor/anti-s factor gene pair. BF3581 is a member of the SusC family of outer membrane proteins. BF3580 is a homologue of SusD, a lipoprotein often paired with SusC. These Sus-like systems have been shown to bind and import a range of oligosaccharide molecules [15] [16] [17] [18] . BF3579 encodes a putative chitobiase, suggesting a possible polysaccharide substrate for this system 19 (Fig. 1e ). Comparative genomic analysis using the Integrated Microbial Genomes database (http://img.jgi.doe.gov/cgi-bin/w/main.cgi) reveals conservation of similar clusters of genes among sequenced intestinal Bacteroides species (Supplementary Fig. 3 ). Sus-like systems are numerous in Bacteroides within polysaccharide utilization loci (PULs), which are gene cassettes used to harvest dietary sugars and/or forage host glycans during nutrient deprivation 15, 20, 21 . As PULs have not previously been implicated in saturable niche colonization, the locus we have identified encodes a unique pathway in Bacteroides for species-specific gut association; we named the genes ccfA-E, for commensal colonization factors ( Fig. 1e ). Furthermore, as deletion of the most closely related genes from B. fragilis (BFD0227-0229; Supplementary Fig. 3 ) do not affect colonization dynamics (Supplementary Fig. 4 ) we suggest that the CCF system represents a functionally unique subset of PULs that evolved to promote long-term symbiosis.
To test whether the putative structural genes (ccfC-E) are required for gut colonization, we generated in-frame deletion mutants of B. fragilis: DccfC, DccfD and DccfE. All strains exhibit normal morphology on solid agar medium and unimpaired growth in laboratory culture (data not shown). As shown previously, animals mono-colonized with wild-type B. fragilis completely clear the wild-type challenge strain after 30 days ( Fig. 1f ; first bars). However, animals mono-associated with DccfC or DccfD are permissive to colonization by wild-type bacteria ( Fig. 1f ; second and third bars), unlike the ccfE mutant ( Fig. 1f ; fourth bars). A deletion mutant in all three genes (BFDCCF) also allows wild-type B. fragilis to colonize ( Fig. 1f ; fifth bars). Trans-complementation of the BFDCCF strain with ccfA-E restores colonization resistance ( Fig. 1f ; sixth bars). Similarly, a mutant in the B. vulgatus ccfC-E orthologues (DBVU0946-BVU0948) also permits wild-type B. vulgatus to colonize ( Fig. 1g ), demonstrating conservation in Bacteroides species. When we tested horizontal transmission of bacteria between wild-type B. fragilis Figure 2 | B. fragilis colonization of the colonic crypts is mediated by the CCF system. a, Quantitative PCR with reverse transcription (qRT-PCR) of ccf gene expression levels normalized to 16S rRNA (n 5 3 animals, 2 trials). b, Mice were mono-associated with either wild-type B. fragilis or BFDCCF, and challenged with wild-type B. fragilis. The percentage of challenge strain was determined in the lumen (faeces) and colon after 1 day (n 5 8 animals per group). c, Confocal micrographs of germ-free, wild-type B. fragilis or BFDCCF mono-associated mice colon whole-mount. Crypts are visualized by DAPI (49,6-diamidino-2-phenylindole; nuclei, blue) and phalloidin (F-actin, green). Bacteria (red) are stained with IgY polyclonal antibody raised against B. fragilis. Images are representative of seven different sites analysed from at least two different colons. Scale bars, 5 mm. d, Three-dimensional reconstructions of colon crypts from wild-type B. fragilis or BFDCCF mono-associated mice. Bacteria are detected on the apical surface of the epithelium (arrows) and in the crypt space (arrowhead). Scale bars, 10 mm. e, Quantification of bacterial penetration, measured as distance from the epithelial surface per crypt. Error bars indicate s.e.m. GF, germ-free; ND, not detected; NS, not significant; rel.unit, relative unit; WT, wild type. **P , 0.01; ****P , 0.0001.
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and BFDCCF mono-associated mice, only wild-type bacteria crosscolonized ( Fig. 1h ). Thus, the CCF system is involved in colonization resistance by Bacteroides.
Building on the previous discovery that a population of B. fragilis associates with mucosal tissues 22 , we show that ccfB-E are preferentially expressed by bacteria in contact with the colon, with lower levels in caecal content and faeces ( Fig. 2a ). There is virtually no expression in laboratory culture. Thus, in vivo expression of ccf in gut tissue may be critical for colonization. Indeed, in contrast to laboratory-grown bacteria (see Fig. 1c ), sustained colonization is conferred to bacteria recovered directly from animals ( Supplementary Fig. 5 ). To examine regulation of gene expression, we deleted the s factor ccfA, which led to highly reduced expression of all five genes during animal colonization ( Supplementary Fig. 6a ). Accordingly, germ-free mice mono-colonized with the B. fragilis DccfA mutant are permissive of super-colonization by wild-type B. fragilis, demonstrating a functional defect in the saturable niche occupancy ( Supplementary Fig. 6b ). On the basis of this tissue-associated expression pattern, we tested whether the CCF system promotes bacterial localization to mucosal tissue. Mice were monoassociated with either the wild-type or the ccf deletion strain, and both groups were subsequently challenged with wild-type B. fragilis. Twentyfour hours after challenge, we observed the same numbers for challenge strains in faeces of both groups ( Fig. 2b first and second bars, and Supplementary Fig. 7a, b ). By contrast, ccf-mutant-associated animals show higher levels of challenge strain in colon tissue, suggesting a colonization defect by the mutant strain specifically at the mucosal surface ( Fig. 2b third and fourth bars, and Supplementary Fig. 7a, b) . Therefore, CCF-mediated colonization fitness seems to involve physical association with the gut.
Recent studies have revealed microbial communities that colonize intestinal crypts of conventional mice in the absence of disease 23 , and we have shown that B. fragilis occupies the colonic crypts of monoassociated mice 22 . Discovering a role for ccf genes near mucosal tissue led us to explore the intriguing hypothesis that the CCF system mediates crypt occupancy. We mono-colonized mice with B. fragilis and visualized bacterial localization in colon tissue by whole-mount confocal microscopy. Indeed, wild-type B. fragilis co-localize with crypts from the ascending colon, appearing to be located in the centre of crypt opening. Notably, BFDCCF mono-associated mice display virtually no crypt occupancy ( Fig. 2c and Supplementary Fig. 8 ). Colon cross-section imaging also reveals that only wild-type bacteria are crypt associated ( Supplementary Fig. 9 ). Two-photon imaging of colon explants clearly demonstrates the presence of wild-type B. fragilis on the surface of the epithelium and inside the crypt. Although both wild-type and mutant strains of B. fragilis associate with the surface of the epithelium, only wildtype bacteria are able to penetrate deep into the colonic crypts of mice ( Fig. 2d and Supplementary Video 1) . Measuring the distance from the surface of the epithelium to bacterial signals in a survey of crypts reveals significantly greater tissue penetration by wild-type bacteria ( Fig. 2e ). Collectively, these data reveal that the CCF system allows B. fragilis to reside in a specific niche within crypts during steady-state colonization.
We next investigated the effects of the CCF system in the context of a complex microbiota. Wild-type Bacteroides species do not readily colonize most strains of specific pathogen-free (SPF) mice, namely BALB/c, Swiss Webster and C57BL/6, despite oral administration of high inoculums ( Supplementary Fig. 10a , c and data not shown). Furthermore, transfer of an SPF microbiota to mono-colonized mice leads to clearance of wild-type B. fragilis ( Supplementary Fig. 10b, d) . To overcome this obstacle, we tested various additional genetic backgrounds and empirically determined that C57BL/6 Rag 2/2 mice (which lack an adaptive immune system) and non-obese diabetic (NOD) mice can be stably colonized by B. fragilis with a single oral gavage. We introduced either wild-type or ccf mutant B. fragilis at equal inoculums into separate groups of animals, and measured colonization. Only wild-type B. fragilis stably colonizes SPF Rag 2/2 mice, whereas BFDCCF establishes a significantly lower colonization in the gut (Fig. 3a) . Co-inoculation of equal numbers of wild-type and ccf mutant bacteria into Rag 2/2 mice also results in rapid clearance of the mutant strain from the gut (Fig. 3b) , demonstrating a cell-intrinsic defect that could not be complemented in trans by wild-type bacteria. NOD animals are also preferentially colonized by wild-type B. fragilis compared to ccf mutants in separate groups of animals ( Fig. 3c ) or in equal co-inoculation (Fig. 3d) . These data show that deletion of the ccf genes compromises B. fragilis colonization of hosts with a complex microbiota.
During symbiosis with mammals, the microbiota may be confronted by rapid environmental changes with potentially adverse consequences to bacteria, such as enteric infections or antibiotic exposure. Gastroenteritis is commonly experienced by humans and is known to perturb the microbiota. To test whether resilience of B. fragilis colonization is CCF-dependent, we used C. rodentium infection of mice to mimic human gastrointestinal tract infection 24 . Using an antibiotic treatment protocol that does not sterilize the gut but promotes colonization of SPF mice by Bacteroides 25 , we were able to simultaneously colonize mice with equivalent levels of wild-type and ccf mutant bacteria. Mice were subsequently infected orally with C. rodentium, and colonization of B. fragilis was monitored. Wild-type bacteria decline in number at first, but return to maximal levels 3-4 weeks after infection (Fig. 3e) . Importantly, the BFDCCF strain is completely cleared from the mouse 
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gut after gastroenteritis (Fig. 3e ), but not when animals are left uninfected ( Supplementary Fig. 11a ). Next, we challenged mice that were cocolonized with wild-type and BFDCCF with oral antibiotics and observe a colonization defect only in ccf mutant bacteria ( Fig. 3f and Supplementary Fig. 11b ). These results reveal that the CCF system establishes resilient colonization by gut Bacteroides following disruption of the microbiome. Finally, when SPF mice colonized with wild-type B. fragilis were given an antibiotic treatment that cleared faecal bacteria, cryptassociated microbial populations persisted ( Supplementary Fig. 12 ), suggesting that symbiotic bacteria occupy a protected niche that creates a reservoir for stable gut colonization.
Co-evolution has bound microbes and man in an inextricable partnership, resulting in remarkable specificity and stability of the human microbiome 2,3 . Our findings reveal a novel pathway required for persistent colonization of the mammalian gut by the Bacteroides. Homology to the Sus family of proteins suggests a role for CCF in uptake and use of glycans. Although certain Sus-containing PULs in B. thetaiotaomicron mediate foraging of host mucus 15 , their contributions to microbial colonization have been previously described only during nutrient deprivation conditions 20 . Our discovery of CCF-dependent colonization in mice fed a nutrient-rich diet suggests a new role whereby Bacteroides evolved specific Sus-like systems to use non-dietary glycans during homeostasis. On the basis of findings that ccf genes are preferentially expressed in proximity to mucosal tissues and B. fragilis associates with colonic crypts, we find it likely that host factors may promote expression of the CCF system. In support of this notion, N-acetyl-D-lactosamine (LacNAc)-a component of host mucus-induces the ccf genes and its homologues in B. fragilis and B. thetaiotaomicron 20 ( Supplementary  Fig. 13 ). But because a closely related PUL (BF0227-31) responds to LacNAc but does not mediate saturable niche colonization (Supplementary Fig. 4 ), LacNAc alone may be an inducer but is not the substrate used by CCF systems. We propose that specific glycan structures within colonic crypts serve as nutrient sources for individual Bacteroides species, and that CCF systems provide a molecular mechanism for a hypothesis proposed decades ago, ''that populations of most indigenous intestinal bacteria are controlled by substrate competition, i.e., that each species is more efficient than the rest in utilizing one or a few particular substrates and that the population level of that species is controlled by the concentration of these few limiting substrates'' 26 . Future work will aim to identify the precise glycan(s) for CCF systems from various Bacteroides. Finally, our data suggest that the ccf genes encode a specific subset of PULs that evolved the novel activity of promoting stable and resilient colonization, and crypt-associated bacterial reservoirs may represent 'founder' cells that repopulate the gut following disruption of the microbiome by enteric infections or antibiotic exposure. Discovery of a molecular mechanism for colonization fitness by gut bacteria provides a glimpse into the evolutionary forces that have shaped the assembly and dynamics of the human microbiome.
METHODS SUMMARY
All germ-free mice were bred and housed in flexible film isolators until 8 weeks of age, then transferred to microisolator cages and maintained with autoclaved food, bedding and water supplemented with gentamicin and erythromycin. Mice were mono-associated with gentamicin-and erythromycin-resistant Bacteroides strains by single oral gavage. Colonization level was determined over time by stool serial dilution plating on selective agar media. For qRT-PCR, total RNA was extracted from laboratory bacterial culture, faecal and caecal content (ZR Soil/Fecal RNA MicroPrep, Zymo Research) and colon tissues (Trizol, Invitrogen) from monoassociated animals, converted to first strand complementary DNA and analysed by qPCR using Power SYBR Green PCR Master Mix (Applied Biosystems). For colon whole-mount imaging, tissues were collected from germ-free or single strain mono-associated animals, fixed with 4% paraformaldehyde and stained with a B. fragilis specific antibody, DAPI and phalloidin. The colon crypts were visualized by confocal microscopy and two-photon microscopy. SPF mice were colonized with B. fragilis and/or BFDCCF by single oral gavage and the colonization level was determined over time by stool DNA extraction (ZR Fecal DNA MiniPrep, Zymo Research) and qPCR using strain specific primers.
METHODS
Bacterial strains, plasmids and culture conditions. Bacterial strains and plasmids are described in Supplementary Table 1 . Bacteroides strains were grown anaerobically at 37 uC for 2 days in brain heart infusion broth supplemented with 5 mg ml 21 hemin and 0.5 mg ml 21 vitamin K (BHIS), with gentamicin (200 mg ml 21 ), erythromycin (5 mg ml 21 ), chloramphenicol (10 mg ml 21 ) and tetracycline (2 mg ml 21 ) added where appropriate. E. coli JM109 containing recombinant plasmids were grown in luria broth (LB) with ampicillin (100 mg ml 21 ) or kanamycin (30 mg ml 21 ). C. rodentium DBS100 strain was grown in LB at 37 uC for 24 h. For the induction of susC/D homologues, B. fragilis and B. thetaiotaomicron were grown in minimal medium with either glucose or N-acetyllactosamine as the sole carbon source as described previously 20 . Mice. 8-10-week old male and female germ-free Swiss Webster mice were purchased from Taconic Farms and bred in flexible film isolators. For gnotobiotic colonization experiments, germ-free mice were transferred to freshly autoclaved microisolator cages, fed ad libitum with a standard autoclaved chow diet and given autoclaved water supplemented with 10 mg ml 21 of erythromycin and 100 mg ml 21 of gentamicin. Male SPF C57BL/6 mice and Swiss Webster mice were purchased from Taconic Farms. Male SPF NOD/ShiLtJ mice and Rag 2/2 C57BL/6 mice were purchased from the Jackson Laboratory. No randomization or blinding was used to allocate experimental groups. Sample size and standard deviation were based on empirical data from pilot experiments. All procedures were performed in accordance with the approved protocols using IACUC guidelines of the California Institute of Technology. Construction of chromosomal library and screen. Genomic DNA was isolated from overnight culture of B. fragilis using a commercial kit (Wizard Genomic DNA Purification Kit, Promega). 20 mg of genomic DNA was incubated with 4 U of Sau3AI for 5, 10, 15 or 20 min at 37 uC in 50 ml volume and the partially digested genomic DNA was separated by electrophoresis on 0.7% agarose gel. 9-10-kb fragment DNA was excised and recovered from the agarose gel (Zymoclean Gel DNA Recovery Kit, Zymo Research). Insert DNA was ligated to BglII site of plasmid vector (pFD340-catBII, Supplementary Table 1 ), transformed into E. coli and amplified on LB-ampicillin plate. Individual clones from the plasmid library were mobilized from E. coli to B. vulgatus by conjugal helper plasmid RK231 generating a library of B. vulgatus hosting B. fragilis chromosomal DNA fragments consisting of approximately ,2,100 clones. To screen the library in vivo, pools of 96 clones (10 6 c.f.u. of each clone) were gavaged into 22 germ-free Swiss Webster mice (10 8 c.f.u. per animal) pre-colonized with B. vulgatus pFD340 for 1-2 weeks. Two weeks after gavage, fresh faecal samples were plated on BHIS agar plate containing chloramphenicol to select for clones with colonization phenotype. Generation of ccfA, ccfC, ccfD, ccfE, ccfC-E (DCCF) and DBF0227-0229 deletion mutants. ,2-kb DNA segments flanking the region to be deleted were PCR amplified using primers listed in Supplementary Table 2 . Reverse primer of the left-flanking DNA and forward primer of the right-flanking DNA were designed to be partially complementary at their 59 ends by 18-21 bp. Fusion PCR was performed using the left and right flanking DNA (,300 ng each after gel purification) as DNA template and forward primer of the left-flanking DNA and reverse primer of the right-flanking DNA 27 . The fused PCR product was cloned into BamHI or SalI site of the Bacteroides conjugal suicide vector pNJR6 and mobilized into B. fragilis. Colonies selected for erythromycin resistance (Em r ), indicating integration of the suicide vector into the host chromosome were passaged for 5 days and then plated on nonselective medium (BHIS). The resulting colonies were replica plated to BHIS containing Em, and Em s (erythromycin sensitive) colonies were screened by PCR to distinguish wild-type revertants from strains with the desired mutation. The same strategy was used to generate DccfC-E deletion mutants from B. vulgatus. qRT-PCR. Total RNA was extracted from mid-log phase bacterial culture using ZR Fungal/Bacterial RNA MiniPrep (Zymo Research), faeces and caecal content from mice using ZR Soil/Fecal RNA MicroPrep (Zymo Research), and mouse colon tissues after removing luminal content by gently scraping the mucosal surface and PBS rinse using Trizol (Invitrogen). Complementary DNA was made using an iSCRIPT cDNA synthesis kit per manufacturer's instructions (Bio-Rad). All qRT-PCR reactions were performed in ABI PRISM 7900HT Fast Real-Time PCR System (Applied Biosystems) using Power SYBR Green PCR Master Mix (Applied Biosystems). Gene-specific primers are described in Supplementary  Table 2 . Immunofluorescent staining of colon whole-mounts and frozen sections. For whole-mount staining, colons were fixed in buffered 4% paraformaldehyde, washed with PBS and subjected to indirect immunofluorescence. Tissues were made permeable by incubation with 0.5% (wt/vol) saponin, 2% (vol/vol) FBS and 0.09% (wt/vol) azide in PBS for at least 18 h. The same buffer was used for subsequent incubations with antibodies. Colon fragments were incubated with a primary polyclonal chicken IgY anti-B. fragilis antibodies for 12-16 h at room temperature followed by 1-2 h incubation at 37 uC. Following PBS washes, samples were reacted with goat anti-chicken IgY secondary antibodies (Alexa Fluor 488 or Alexa Fluor 633, 2 mg ml 21 , Molecular Probes), fluorescently labelled phalloidin (fluorescein or AF568, 2 U ml 21 , Molecular Probes) and DAPI (2 mg ml 21 , Molecular Probes) for 1 h at room temperature. Tissues were mounted in Prolong Gold (Invitrogen) and allowed to cure for at least 48 h before imaging. In some experiments, anti-B. fragilis antibodies were pre-absorbed on tissue fragments derived from either germ-free mice (up to 18 h at room temperature) or SPF mice (1 h at room temperature).
For frozen sections, colon tissues were embedded in OCT Compound (Sakura Finetek), frozen on dry ice and stored at 280 uC. Frozen blocks were cut with a thickness of 10 mm using a Microm HM505E cryostat, and sections were collected on positively charged slides (Fisher Scientific) for staining. Slides were fixed with 4% buffered paraformaldehyde for 10 min and washed 2 3 10 min with PBS. Tissue sections were blocked with 10% normal goat serum and 0.5% bovine serum albumin in PBS for 1 h at room temperature. Sections were incubated with anti-B. fragilis antibodies for at least 8 h at 4 uC, washed twice for 10 min with PBS, reacted with secondary reagents and mounted as described above. In some experiments, anti-B. fragilis antibodies were pre-absorbed for 1 h at room temperature on tissue sections derived from germ-free mice. Fluorescence microscopy. An SP5 resonant laser-scanning confocal and twophoton microscope (both scanning heads mounted on the same DM 6000 upright microscope, Leica Microsystems) with a 403 oil objective (numerical aperture 1.4) or 633 oil objective (numerical aperture 1.4) were used for fluorescence microscopy. Images used for three-dimensional reconstructions were acquired using dual confocal-two-photon mode. For confocal imaging, 488-nm and 543-nm excitation wavelengths were used for Alexa Fluor 488-labelled bacteria and Alexa Fluor 568-labelled phalliodin, and signals were detected with internal photomultiplier tubes. Two-photon imaging was performed with four nondescanned detectors (Leica Microsystems) and a Chameleon Ultra Ti: Sapphire laser (Coherent) tuned at 700-800 nm for acquisition. Emitted fluorescence was split with three dichroic mirrors (496 nm, 560 nm and 593 nm) and passed through an emission filter (Semrock) at 585/40 nm. Images (512 3 512) acquired with a 0.5-mm Z step were smoothed by median filtering at kernel size 3 3 3 pixels. Three-dimensional reconstructions of crypts and bacteria were performed using Imaris software (version 7.5.1 3 64; Bitplane AG). Crypt structures were visualized by DAPI and phalloidin signals. Images used for quantification were acquired with FluoView FV10i confocal microscope (Olympus) using 603 (numerical aperture 1.35) oil objective. Image analysis. For bacterial localization with respect to the epithelial layer, frames of 512 3 512 pixels were acquired with 1-mm Z steps in the crypt length axis. Images were processed using ImageJ software (NIH). Background was subtracted (rolling ball method), images were smoothed by median filtering (3 3 3 pixels), segmented by threshold and position of the signal in the Z stack was recorded. Data did not follow normal distribution and were analysed by nonparametric two-sided Mann-Whitney U-test.
For quantification of crypt-associated bacterial signals from antibiotic-treated animals, stacks of 512 3 512 pixels by eight frames (1 mm per frame) were flattened by maximum intensity projection and filtered by median (3 3 3 kernel size). Images were segmented by thresholding. Number of positive spots per 1,000 mm 2 and area occupied by individual spots were analysed. Data were not normally distributed and were analysed by Mann-Whitney or Kruskal-Wallis followed by Dunn's multiple comparisons test where appropriate. 11-13 stacks/group were examined. Total area that was analysed within the group of stacks was between 0.08-0.2 mm 2 . Gnotobiotic animal colonization experiments. 8-12-week-old germ-free Swiss Webster mice were gavaged once with a 100 ml of bacterial suspension for monoassociation (,10 8 c.f.u. of each bacterial strain collected from a log-phase culture and re-suspended in PBS with 1.5% NaHCO 3 ). For sequential colonization, germfree mice were mono-associated with an initial strain for 6-7 days and subsequently gavaged with a 100 ml suspension of a challenge strain. All Bacteroides strains used to colonize germ-free animals were resistant to gentamicin inherently, and to erythromycin by plasmid. Unless otherwise indicated, the initial strains carried pFD340-cat (chloramphenicol resistant; Cm r ) and the challenge strains, pFD340-tetQ (tetracycline resistant; Tet r ). For horizontal transfer by encounter experiment, two single-housed mice that were mono-associated with either wildtype B. fragilis pFD340-tetQ or BFDCCF pFD340-cat for at least 3 weeks were cohoused in a fresh sterile cage for 4 h and then separated. At each time point, fresh faecal samples were collected, weighed, homogenized and serially diluted in PBS (or BHI broth) for plating on selective media to determine bacterial c.f.u. per g of faeces. SPF animal colonization experiments. 7-8-week-old male SPF mice (C57BL/6, Swiss Webster, NOD and Rag 2/2 ) were given a single inoculum of 1 3 10 8 c.f.u. of either wild-type B. fragilis, BFDCCF or 1:1 mixture of the two strains by oral RESEARCH LETTER
